These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3111903)

  • 1. Production and purification of eta (ETA) precipitinogen, species-specific to mycobacterium tuberculosis and its intradermal reactivity.
    Hirai T; Yamanouchi T
    Dev Biol Stand; 1986; 58 ( Pt B)():565-8. PubMed ID: 3111903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A system for preparation, detection and identification of a precipitinogen (eta) of strains of Mycobacterium tuberculosis, that is not detectable in strains of M. bovis.
    Hirai T; Shimmen Y; Yoneda M
    Biken J; 1982 Mar; 25(1):1-19. PubMed ID: 6812563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of immunizing and delayed hypersensitivity eliciting antigens of Mycobacterium leprae, M. tuberculosis, M. vaccae, and M. bovis (BCG).
    Sinha S; Sreevatsa ; Gupta SK; Sengupta U
    Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):42-53. PubMed ID: 2435824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunologic characterization of fractions of the BCG strain of M. bovis isolated by chromatofocusing].
    Nyabenda J; Pierre M; Keuterickx F; de Backer P
    Dev Biol Stand; 1986; 58 ( Pt A)():43-52. PubMed ID: 3297875
    [No Abstract]   [Full Text] [Related]  

  • 5. The isolation from romanian BCG substrain of non cross reacting antigens to Mycobacterium tuberculosis H37Rv strain.
    Niculescu D; Stavri D; Stavri H; Claiciu I; Bărbulescu R
    Arch Roum Pathol Exp Microbiol; 1983; 42(2-3):213-9. PubMed ID: 6424629
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of Mycobacterium tuberculosis specific RD antigens for delayed type hypersensitivity responses in guinea pig.
    Kalra M; Khuller GK; Sheikh JA; Verma I
    Indian J Exp Biol; 2010 Feb; 48(2):117-23. PubMed ID: 20455320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative testing of the potency of different PPD preparations.
    Zsidai J; Joó I
    Dev Biol Stand; 1986; 58 ( Pt B)():599-605. PubMed ID: 3111905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of a BCG substrain specific elicitin.
    Niculescu D; Stavri D
    Arch Roum Pathol Exp Microbiol; 1981; 40(2):117-22. PubMed ID: 7030273
    [No Abstract]   [Full Text] [Related]  

  • 9. Mycobacterium bovis BCG vaccination modulates TNF-alpha production after pulmonary challenge with virulent Mycobacterium tuberculosis in guinea pigs.
    Yamamoto T; Lasco TM; Uchida K; Goto Y; Jeevan A; McFarland C; Ly L; Yamamoto S; McMurray DN
    Tuberculosis (Edinb); 2007 Mar; 87(2):155-65. PubMed ID: 17289434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.
    de Lisle GW; Wards BJ; Buddle BM; Collins DM
    Tuberculosis (Edinb); 2005; 85(1-2):73-9. PubMed ID: 15687030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and purification of immunologically reactive DPPD, a recombinant Mycobacterium tuberculosis skin test antigen, using Mycobacterium smegmatis and Escherichia coli host cells.
    Liu C; Flamoe E; Chen HJ; Carter D; Reed SG; Campos-Neto A
    Can J Microbiol; 2004 Feb; 50(2):97-105. PubMed ID: 15052311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proceedings: Cross reactions between mycobacterial antigens.
    Rees RJ
    Ann Sclavo; 1971; 13(6):430-46. PubMed ID: 5005892
    [No Abstract]   [Full Text] [Related]  

  • 13. Delayed-type hypersensitivity to a recombinant mycobacterial antigen, MPB64, in guinea pigs sensitized to Mycobacterium tuberculosis or Mycobacterium bovis BCG.
    Haga S; Yamaguchi R; Nagai S; Matsuo K; Yamazaki A; Nakamura RM
    J Leukoc Biol; 1995 Feb; 57(2):221-5. PubMed ID: 7531745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.
    Sun R; Skeiky YA; Izzo A; Dheenadhayalan V; Imam Z; Penn E; Stagliano K; Haddock S; Mueller S; Fulkerson J; Scanga C; Grover A; Derrick SC; Morris S; Hone DM; Horwitz MA; Kaufmann SH; Sadoff JC
    Vaccine; 2009 Jul; 27(33):4412-23. PubMed ID: 19500523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of biologically active components of Mycobacterium bovis, using Triton X-100 or potassium chloride.
    Hall MR; Thoen CO
    Am J Vet Res; 1983 Aug; 44(8):1602-4. PubMed ID: 6354016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative cross reactivity of habanin, lepromin and tuberculin in guinea pigs sensitized with homologous and heterologous mycobacteria.
    Singh NB; Srivastava A; Gupta HP; Kumar A; Chaturvedi VK
    Indian J Lepr; 1988 Jul; 60(3):407-12. PubMed ID: 3143770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Mycobacterium bovis intranasal challenge model in mice.
    Logan KE; Gavier-Widen D; Hewinson RG; Hogarth PJ
    Tuberculosis (Edinb); 2008 Sep; 88(5):437-43. PubMed ID: 18590980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of ESAT-6.
    Aggerbeck H; Madsen SM
    Tuberculosis (Edinb); 2006 Sep; 86(5):363-73. PubMed ID: 16352469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination.
    Young SL; Slobbe L; Wilson R; Buddle BM; de Lisle GW; Buchan GS
    Infect Immun; 2007 Jun; 75(6):2833-40. PubMed ID: 17371857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on diagnostic potential of secretory antigens of Mycobacterium bovis.
    Trivedi S; Das SK; Kumar R; Chandra R
    Indian J Exp Biol; 2006 Jan; 44(1):14-8. PubMed ID: 16430085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.